These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 2351612)

  • 1. Synthesis and cytostatic activity of the antitumor antibiotic chartreusin derivatives.
    Kon K; Sugi H; Tamai K; Ueda Y; Yamada N
    J Antibiot (Tokyo); 1990 Apr; 43(4):372-82. PubMed ID: 2351612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of analogues of the antitumor antibiotic chartreusin.
    Takai M; Uehara Y; Beisler JA
    J Med Chem; 1980 May; 23(5):549-53. PubMed ID: 7381855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159).
    McGovren JP; Neil GL; Crampton SL; Robinson MI; Douros JD
    Cancer Res; 1977 Jun; 37(6):1666-72. PubMed ID: 870180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
    Schurig JE; Bradner WT; Basler GA; Rose WC
    Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
    Konishi M; Sugawara K; Kofu F; Nishiyama Y; Tomita K; Miyaki T; Kawaguchi H
    J Antibiot (Tokyo); 1986 Jun; 39(6):784-91. PubMed ID: 3733527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues.
    Jouin P; Poncet J; Dufour MN; Aumelas A; Pantaloni A; Cros S; François G
    J Med Chem; 1991 Feb; 34(2):486-91. PubMed ID: 1995869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calicheamicins, a novel family of antitumor antibiotics: taxonomy, fermentation and biological properties.
    Maiese WM; Lechevalier MP; Lechevalier HA; Korshalla J; Kuck N; Fantini A; Wildey MJ; Thomas J; Greenstein M
    J Antibiot (Tokyo); 1989 Apr; 42(4):558-63. PubMed ID: 2722671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of kijanimicin.
    Bradner WT; Claridge CA; Huftalen JB
    J Antibiot (Tokyo); 1983 Aug; 36(8):1078-9. PubMed ID: 6630059
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antineoplastic effect of violamycins and lambdamycin in experimental leukemias].
    Gutsche W; Jungstand W; Wohlrabe K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):647-51. PubMed ID: 6172328
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of IST-622, a novel synthetic derivative of chartreusin, against murine and human tumor lines following oral administration.
    Tashiro T; Kon K; Yamamoto M; Yamada N; Tsuruo T; Tsukagoshi S
    Cancer Chemother Pharmacol; 1994; 34(4):287-92. PubMed ID: 8033294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vivo antitumor activity of novel mitomycin A disulfide analogs.
    Vyas DM; Benigni D; Rose WC; Bradner WT; Doyle TW
    J Antibiot (Tokyo); 1989 Jul; 42(7):1199-201. PubMed ID: 2753826
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 15. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W; Neamati N; Perez-Soler R
    J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumour activity of some cyclophosphazenes.
    Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
    Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Ishikura T
    J Antibiot (Tokyo); 1982 Mar; 35(3):312-20. PubMed ID: 6951827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydramycin, a new antitumor antibiotic. Taxonomy, isolation, physico-chemical properties, structure and biological activity.
    Hanada M; Kaneta K; Nishiyama Y; Hoshino Y; Konishi M; Oki T
    J Antibiot (Tokyo); 1991 Aug; 44(8):824-31. PubMed ID: 1833366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L; Narayanan VL; Paull KD
    J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.